000 01409 a2200385 4500
005 20250516051110.0
264 0 _c20111025
008 201110s 0 0 jpn d
022 _a0917-5857
024 7 _aCliCa110811671174
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbe, Masahiro
245 0 0 _a[Myeloma bone disease and RANKL signaling].
_h[electronic resource]
260 _bClinical calcium
_cAug 2011
300 _a1167-74 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAdaptor Proteins, Signal Transducing
_xphysiology
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aBone Resorption
_xgenetics
650 0 4 _aCell Differentiation
_xgenetics
650 0 4 _aDenosumab
650 0 4 _aHumans
650 0 4 _aMacrophage Inflammatory Proteins
_xphysiology
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMultiple Myeloma
_xdrug therapy
650 0 4 _aOsteoblasts
_xcytology
650 0 4 _aOsteoclasts
_xcytology
650 0 4 _aRANK Ligand
_ximmunology
650 0 4 _aRepressor Proteins
_xphysiology
650 0 4 _aSignal Transduction
_xphysiology
650 0 4 _aTransforming Growth Factor beta
_xphysiology
773 0 _tClinical calcium
_gvol. 21
_gno. 8
_gp. 1167-74
856 4 0 _uhttps://doi.org/CliCa110811671174
_zAvailable from publisher's website
999 _c21059363
_d21059363